Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease Evaluated by Real-time Ultrasonography: A Randomized Double-blinded Clinical Trial
Phase of Trial: Phase III
Latest Information Update: 05 Jun 2018
At a glance
- Drugs DA 9701 (Primary) ; Domperidone
- Indications Constipation; Dyspepsia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Jun 2018 Primary endpoint (Change of gastric motility evaluated using MRI from baseline at 4 weeks after the treatment) has been met, according to results presented at the Digestive Disease Week 2018.
- 05 Jun 2018 Results presented at the Digestive Disease Week 2018.